1. Key Lab of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education & Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, Huazhong Agricultural University, Wuhan 430070, China 2. College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China
Previous studies indicated that miR-29c is important for muscle development in mice and human, but its role in pigs is unknown. In this study, we detected the expression of miR-29c in Meishan longissimus lumborum (LL) muscle. The results showed that miR-29c was gradually upregulated during development of skeletal muscle in pig. Moreover, the expression of YY1 and Akt3 genes, which were confirmed to be targeted by miR-29c in mice, was decreased along with muscle development. Furthermore, the expression level of miR-29c was significantly higher in adult Meishan pigs than Large White pigs, while the expression of YY1 and Akt3 genes was significantly lower in Meishan pigs. These results indicated that the expression pattern of miR-29c was opposite to that of YY1 and Akt3 genes in pigs. Also, the luciferase assay indicated that miR-29s can target the YY1 gene in pigs. In addition, we identified a T to C mutation in the primary transcript of miR-29c, which was associated with the postmortem muscle pH in pigs. Based on these results, we concluded that miR-29c is also important in skeletal muscle development of pigs.
. [J]. Frontiers of Agricultural Science and Engineering, 2015, 2(4): 311-317.
Weiya ZHANG,Wei WEI,Yuanyuan ZHAO,Shuhong ZHAO,Xinyun LI. The microRNA, miR-29c, participates in muscle development through targeting the YY1 gene and is associated with postmortem muscle pH in pigs. Front. Agr. Sci. Eng. , 2015, 2(4): 311-317.
Brozinick J T Jr, Roberts B R, Dohm G L. Defective signaling through Akt-2 and-3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes, 2003, 52(4): 935–941
https://doi.org/10.2337/diabetes.52.4.935
2
Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge D C, Sun H, Wang H. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Molecular Therapy, 2012, 20(6): 1222–1233
https://doi.org/10.1038/mt.2012.35
Tiao M M, Wang F S, Huang L T, Chuang J H, Kuo H C, Yang Y L, Huang Y H. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis, 2012, 19(1): 30–41
https://doi.org/10.1007/s10495-013-0909-4
5
Kwiecinski M, Elfimova N, Noetel A, Töx U, Steffen H M, Hacker U, Nischt R, Dienes H P, Odenthal M. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Laboratory Investigation, 2012, 92(7): 978–987
https://doi.org/10.1038/labinvest.2012.70
6
Wei W, He H B, Zhang W Y, Zhang H X, Bai J B, Liu H Z, Cao J H, Chang K C, Li X Y, Zhao S H. MiR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death & Disease, 2013, 4(6): e668
https://doi.org/10.1038/cddis.2013.184
7
Kriegel A J, Liu Y, Fang Y, Ding X, Liang M. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiological Genomics, 2012, 44(4): 237–244
https://doi.org/10.1152/physiolgenomics.00141.2011
8
Ouyang Y B, Xu L, Lu Y, Sun X, Yue S, Xiong X X, Giffard R G. Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Wiley Periodicals, 2013, 61: 1784–1794
9
Nijhuis A, Biancheri P, Lewi A, Bishop C L, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A, Corazza G R, MacDonald T T, Lindsay J O, Silver A R. In Crohn’s disease fibrosis reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clinical Science, 2014, 127(5): 341–350
https://doi.org/10.1042/CS20140048
10
Bandyopadhyay S, Friedman R C, Marquez R T, Keck K, Kong B, Icardi M S, Brown K E, Burge C B, Schmidt W N, Wang Y, McCaffrey A P. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. Journal of Infectious Diseases, 2011, 203(12): 1753–1762
https://doi.org/10.1093/infdis/jir186
11
Morita S, Horii T, Kimura M, Ochiya T, Tajima S, Hatada I. MiR-29 represses the activities of DNA methyltransferases and DNA demethylases. International Journal of Molecular Sciences, 2013, 14(7): 14647–14658
https://doi.org/10.3390/ijms140714647
12
Franceschetti T, Kessler C B, Lee S K, Delany A M. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. Journal of Biological Chemistry, 2013, 288(46): 33347–33360
https://doi.org/10.1074/jbc.M113.484568
13
Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. European Journal of Cell Biology, 2013, 92(3): 123–128
https://doi.org/10.1016/j.ejcb.2012.11.004
14
Wang H, Garzon R, Sun H, Ladner K J, Singh R, Dahlman J, Cheng A, Hall B M, Qualman S J, Chandler D S, Croce C M, Guttridge D C. NF-κB–YY1–miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell, 2008, 14(5): 369–381
https://doi.org/10.1016/j.ccr.2008.10.006
15
CaLLara F R, Moi M, dos Santos Luan S. Carcass characteristics and qualitative attributes of pork from immunocastrated animals. Asian-Australas Journal of Animal Science, 2013，26(11): 1630–1636
16
Zhou L, Wang L, Lu L, Jiang P, Sun H, Wang H. A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis. Journal of Biological Chemistry, 2012, 287(30): 25255–25265
https://doi.org/10.1074/jbc.M112.357053
17
Kalenik J L, Chen D, Bradley M E. Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Research, 1997, 25(4): 843–849
18
Shi Y, Seto E, Chang L S, Shenk T. Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein. Cell, 1991, 67(2): 377–388
https://doi.org/10.1016/0092-8674(91)90189-6
19
Lu L, Zhou L, Chen E Z, Sun K, Jiang P, Wang L, Su X, Sun H, Wang H. A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PLoS ONE, 2012, 7(2): e27596
https://doi.org/10.1371/journal.pone.0027596
20
Monin G, Sellier P. Pork of low technological quality with a normal rate of muscle pH fall in the immediate post-mortem period: the case of the Hampshire breed. Meat Science, 1985, 13(1): 49–63
https://doi.org/10.1016/S0309-1740(85)80004-8
21
Sterten H, Oksbjerg N, Frøystein T, EkkerA S, Kjos N P. Effects of fasting prior to slaughter on pH development and energy metabolism post-mortem in M. longissimus dorsi of pigs. Meat Science, 2010, 84(1): 93–100
22
Cunningham J T, Rodgers J T, Arlow D H, Vazquez F, Mootha V K, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature, 2007, 450(7170): 736–740
https://doi.org/10.1038/nature06322
23
Dummler B, Tschopp O, Hynx D, Yang Z Z, Dirnhofer S, Hemmings B A. Life with a single Isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Molecular and Cellular Biology, 2006, 26(21): 8042–8051
https://doi.org/10.1128/MCB.00722-06
24
Blattler S M, Cunningham J T, Verdeguer F, Chim H, Haas W, Liu H, Romanino K, Ruegg M A, Gygi S P, Shi Y, Puigserver P. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metabolism, 2012, 15(4): 505–517
https://doi.org/10.1016/j.cmet.2012.03.008
